![]() |
|
|
Vol. 295, Issue 3, 1284-1290, December 2000
Laboratory of Muscle Research and Molecular Cardiology, Clinic III
of Internal Medicine (K.B., R.H.G.S.), Clinic of Cardiothoracic Surgery
(U.M.), and Institute I of Anatomy (W.B.), University of Cologne,
Köln, Germany
Ca2+ sensitizers may be advantageous for treatment in human
heart failure by increasing cardiac force without increasing the Ca2+ transient or energy consumption. To study the mode of
action of the Ca2+ sensitizers EMD 57033 (EMD) and CGP
48506 (CGP), their influence on butanedione monoxime (BDM)-mediated
depression of cross-bridge cycling was analyzed in human myocardium
(explanted hearts, dilated cardiomyopathy, n = 19).
In Triton X (1%)-skinned fiber preparations of left ventricular
myocardium from patients suffering from dilated cardiomyopathy,
troponin I was extracted by vanadate (10 mM) treatment, resulting in a
Ca2+-independent contraction. In troponin I-depleted fibers
BDM (5-50 mM) was applied in the absence and presence of EMD (10 µM)
or CGP (10 µM). To analyze the influence on cross-bridge kinetics, tension cost (ratio of ATPase activity and tension development) was
studied. BDM exerted a dose-dependent force inhibition in troponin
I-depleted fibers (IC50 = 7.22 mM), which was
antagonized by EMD (IC50 of BDM + EMD = 19.97 mM) and
CGP (IC50 of BDM + CGP = 15.30 mM). EMD increased
Ca2+ sensitivity of force and maximal force in Triton
X-skinned fibers. The Ca2+-sensitizing effect of CGP was
accompanied by an increased Ca2+ sensitivity of
myosin-ATPase activity, an increased slope of the Ca2+
force and Ca2+ ATPase curve, as well as a reduced maximal
myosin ATPase activity. CGP and EMD reduced tension cost. In
conclusion, EMD and CGP antagonize the BDM-mediated relaxation in
troponin I-depleted cardiac muscle fibers. The
Ca2+-sensitizing effect of CGP seems to be dependent on an
improvement of the myofilament cooperativity, whereas EMD seems to
operate by increasing the force per cross-bridge.
This article has been cited by other articles:
![]() |
Z. Chen, W. Huang, T. Dahme, W. Rottbauer, M. J. Ackerman, and X. Xu Depletion of zebrafish essential and regulatory myosin light chains reduces cardiac function through distinct mechanisms Cardiovasc Res, July 1, 2008; 79(1): 97 - 108. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Frey, K. Brixius, R. H. G. Schwinger, T. Benis, A. Karpowski, H. P. Lorenzen, M. Luedde, H. A. Katus, and W. M. Franz Alterations of Tension-dependent ATP Utilization in a Transgenic Rat Model of Hypertrophic Cardiomyopathy J. Biol. Chem., October 6, 2006; 281(40): 29575 - 29582. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. B. Stull, M. K. Leppo, L. Szweda, W. D. Gao, and E. Marban Chronic Treatment With Allopurinol Boosts Survival and Cardiac Contractility in Murine Postischemic Cardiomyopathy Circ. Res., November 12, 2004; 95(10): 1005 - 1011. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. G. Soergel, D. Georgakopoulos, L. B. Stull, D. A. Kass, and A. M. Murphy Augmented systolic response to the calcium sensitizer EMD-57033 in a transgenic model with troponin I truncation Am J Physiol Heart Circ Physiol, May 1, 2004; 286(5): H1785 - H1792. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Communal, M. Sumandea, P. de Tombe, J. Narula, R. J. Solaro, and R. J. Hajjar Functional consequences of caspase activation in cardiac myocytes PNAS, April 30, 2002; 99(9): 6252 - 6256. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Communal, M. Sumandea, P. de Tombe, J. Narula, R. J. Solaro, and R. J. Hajjar Functional consequences of caspase activation in cardiac myocytes PNAS, April 30, 2002; 99(9): 6252 - 6256. [Abstract] [Full Text] [PDF] |
||||